Innovator’s Pitch Challenge
Vakona develops a new, antibiotic-free treatment for acne vulgaris – a natural bacterial enzyme that degrades the bacterial biofilm to open up blocked hair follicles. The enzyme can be used for effective treatment, for example by application through skin cream. Vakona’s treatment does not, as existing drugs, target Propionibacterium acnes, but the biofilm protecting the bacterium from current drugs and the natural defense system. This means that the new drug uses a completely new mechanism of action and has potential to enable significantly shorter treatment time, expected to give effect within a week and without side effects such as skin irritation.